POZZI, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 4.858
EU - Europa 2.976
AS - Asia 2.069
SA - Sud America 388
AF - Africa 222
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.533
Nazione #
US - Stati Uniti d'America 4.780
SG - Singapore 858
IT - Italia 814
CN - Cina 460
UA - Ucraina 373
BR - Brasile 336
RU - Federazione Russa 313
HK - Hong Kong 291
DE - Germania 287
IE - Irlanda 244
SE - Svezia 216
CI - Costa d'Avorio 157
FR - Francia 146
DK - Danimarca 140
FI - Finlandia 137
VN - Vietnam 137
TR - Turchia 112
GB - Regno Unito 99
KR - Corea 81
NL - Olanda 63
IN - India 56
AT - Austria 50
CA - Canada 44
ZA - Sudafrica 29
AR - Argentina 24
MX - Messico 24
PL - Polonia 24
MA - Marocco 19
ES - Italia 18
JP - Giappone 15
AU - Australia 14
BE - Belgio 13
ID - Indonesia 13
RO - Romania 13
BD - Bangladesh 11
EC - Ecuador 11
LT - Lituania 7
IQ - Iraq 6
CL - Cile 5
AE - Emirati Arabi Uniti 4
EU - Europa 4
HR - Croazia 4
UZ - Uzbekistan 4
CO - Colombia 3
EG - Egitto 3
IL - Israele 3
JM - Giamaica 3
KE - Kenya 3
MD - Moldavia 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
DZ - Algeria 2
JO - Giordania 2
OM - Oman 2
PK - Pakistan 2
PY - Paraguay 2
SA - Arabia Saudita 2
SM - San Marino 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BJ - Benin 1
BW - Botswana 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
KG - Kirghizistan 1
MU - Mauritius 1
NP - Nepal 1
NR - Nauru 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.533
Città #
Dallas 698
Ashburn 573
Singapore 541
Chandler 422
Jacksonville 382
Hong Kong 291
Dublin 239
Boardman 234
Fairfield 202
New York 170
Abidjan 157
Wilmington 151
Beijing 117
Marche 113
Des Moines 97
Los Angeles 94
Lawrence 84
Princeton 83
Houston 82
Seattle 82
San Mateo 80
Munich 74
Ann Arbor 69
Moscow 68
Woodbridge 61
Hefei 60
Cambridge 59
Ancona 58
Ho Chi Minh City 54
The Dalles 53
Turin 53
Milan 51
Turku 39
Council Bluffs 38
Centro 37
San Diego 36
Buffalo 35
Vienna 33
Chicago 30
Helsinki 28
Tolentino 27
Recanati 26
Shanghai 26
Hanoi 25
São Paulo 25
London 23
Rome 23
Johannesburg 22
Amsterdam 21
Stockholm 20
Wuhan 20
Brooklyn 19
Chennai 19
Montreal 19
Washington 19
Nuremberg 18
Denver 16
Berlin 15
Warsaw 15
Ankara 14
Aversa 14
Poplar 14
Redmond 14
Brussels 13
Guangzhou 13
Tokyo 13
Boston 12
Brasov 12
Mexico City 12
Atlanta 11
Belo Horizonte 11
Rio de Janeiro 11
Civitanova Marche 10
San Francisco 10
Santa Clara 10
Wuxi 10
Curitiba 9
Delhi 9
Naples 9
Pune 9
Salt Lake City 9
Toronto 9
Haiphong 8
Phoenix 8
Boydton 7
Cagliari 7
Jiaxing 7
Livorno 7
Manchester 7
Norwalk 7
Perugia 7
Pesaro 7
Porto 7
Biên Hòa 6
Da Nang 6
Frankfurt am Main 6
Frederico Westphalen 6
Iesi 6
Jinhua 6
Orem 6
Totale 6.605
Nome #
Cancer stem cell enrichment is associated with enhancement of nicotinamide N-methyltransferase expression 172
Paraoxonase-2 in osteosarcoma: potential for the development of a targeted anticancer therapy 163
Inflammatory cytokines patterns in the placenta of pregnancies complicated by HELLP syndrome. 158
Clinical performance and utility of a NNMT-based urine test for bladder cancer 157
Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma 156
Involvement of the oral cavity in psoriasis: results of a clinical study 140
Aspetti infiammatori, trombotici e immunitari nella biologia dell’aborto spontaneo ricorrente. 135
Expression and prognostic significance of apoptotic genes in oral squamous cell carcinoma 134
Bladder Cancer Chemosensitivity is Affected by Paraoxonase-2 Expression 134
Differential expression of nicotinamide N-methyltransferase in primary and recurrent ameloblastomas and odontogenic keratocysts 134
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 134
Exploring the role of paraoxonase-2 in bladder cancer: analyses performed on tissue samples, urines and cell cultures 133
Espressione della trombomodulina placentare negli aborti spontanei ricorrenti. 131
Betacyanins enhance vitexin-2-O-xyloside mediated inhibition of proliferation of T24 bladder cancer cells 130
Analysis of tissue and salivary nicotinamide N-methyltransferase in oral squamous cell carcinoma: basis for the development of a noninvasive diagnostic test for early-stage disease. 129
RNA-Mediated Gene Silencing of Nicotinamide N-Methyltransferase Is Associated with Decreased Tumorigenicity in Human Oral Carcinoma Cells. 128
Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma. 125
Apoptosis pathway is involved in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome and intrauterine growth restriction (IUGR). 123
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 120
Clues to apoptosis pathway involvement in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome and intrauterine growth restriction (IUGR). 119
Nicotinamide N-methyltransferase in Non-small Cell Lung Cancer: Promising Results for Targeted Anti-cancer Therapy. 118
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 118
Expression of extracellular matrix and adhesion proteins in pelvic organ prolapse 117
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 116
Inflammatory cytokines pattern in recurrent miscarriage. 115
Identification and Characterization of Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma Cell Lines 115
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 115
Role Played by Paraoxonase-2 Enzyme in Cell Viability, Proliferation and Sensitivity to Chemotherapy of Oral Squamous Cell Carcinoma Cell Lines 114
Deepening Cisplatin sensitivity on Oral Squamous cell Carcinoma cell lines after PON2 knockdown: A FTIRM investigation 113
Fattore di differenziamento eritrocitario (EDRF) nella patologia ostetrica. 111
Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test. 109
FTIRM analyses as a tool to explore cisplatin sensitivity of oral squamous cell carcinoma cell lines after PON2 knockdown 108
Association of miR-126 with soluble mesothelin-related peptides: a novel marker for malignant mesothelioma. 106
Role of nicotinamide N-methyltransferase in non-small cell lung cancer: in vitro effect of shRNA-mediated gene silencing on tumorigenicity 106
Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance 105
Treatment of osteosarcoma and Merkel cell carcinoma cell lines with inhibitors of nicotinamide N-methyltransferase: potential for the development of targeted therapeutic strategy 103
L'enzima nicotinamide N-Metiltrasferasi: un nuovo marker diagnostico e target terapeutico nel carcinoma orale 103
Inflammatory cytokines patterns in the placenta of pregnancies complicated by Hellp syndrome. 102
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 102
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 100
CSCs selection, characterization and tumorigenic potential in OSCC. 99
Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis. 98
Cancer stem cells from human tumor cell lines: molecular and phenotypic features 97
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 97
Inflammatory cytokines pattern in recurrent miscarriage. 96
Salivary and tissue Nicotinamide N-methyltrasferase: potential use for early and non-invasive diagnosis of oral squamous cell carcinoma. 96
RNA-mediated gene silencing NNMT decreases tumorigenity in OSCC cells. 96
The involvement of inflammatory cytokines in the pathogenesis of recurrent miscarriage. 95
Enhanced expression of amyloid precursor protein in platelets from patients with Alzheimer’s disease and frontotemporal lobar degeneration. 95
Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression. 94
Pattern di espressione placentare delle citochine infiammatorie nella HELLP syndrome. 94
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 93
Enhancing cisplatin efficacy in triple-negative breast cancer through pon2 silencing: insights from FTIRM analysis 93
Identification and characterization of cancer stem cells from Head and Neck squamous cell carcinoma cell line Hep-2. 92
Enhanced expression of nicotinamide N-methyltransferase in non-small cell lung cancer: potential for the development of a targeted anticancer therapy. 92
Paraoxonase-2 shRNA-mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines 90
Evaluation of urinary Nicotinamide N-methyltransferase: a non-invasive diagnostic test for bladder cancer 90
The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update 90
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 88
FTIR Imaging as a new tool for investigating oral tongue squamous cell carcinoma 87
Molecular and phenotypic characterization of cancer stem cells from human tumor cell lines 87
Paraoxonase-2 expression in oral squamous cell carcinoma 87
Natural extracts from the genus Beta and their cytotoxic activity on T24 human bladder cancer cells 86
Structural Basis of Substrate Recognition in Human Nicotinamide N-Methyltransferase. 85
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches 84
Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies 83
Micro-RNA profiling identifies mir-126 as promising biomarker for prognosis and early detection of malignant mesothelioma. 83
Enhanced expression of paraoxonase 2 in human bladder cancer 83
Characterization of cancer stem cells from larynx and bladder carcinoma cell lines 83
RNA-mediated gene silencing of nicotinamide N-methyltransferase is associated with decreased tumorigenicity in human oral carcinoma cells. 82
Nicotinamide N-methyltransferase as potential diagnostic marker in patients with urinary bladder carcinoma: a real-time approach. 81
Paraoxonase 2 (PON2) expression in bladder cancer 81
Contribution of the Paraoxonase-2 Enzyme to Cancer Cell Metabolism and Phenotypes 80
Quantitative analysis of Nicotinamide N-methyltransferase expression in urine and tumour tissue of bladder cancer patients and its potential relevance for disease detection. 80
Nicotinamide N-methyltransferase: a promising marker for oral cancer. 80
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 80
Catechol-o-methyltransferase, a promising diagnostic marker for non-invasive detection of human urothelial carcinoma 79
Nicotinamide N-methyltransferase, a promising marker for human osteosarcoma 78
Epithelial Biological Response to Machined Titanium vs. PVD Zirconium-Coated Titanium: An In Vitro Study 78
Espressione di Pokemon nel carcinoma orale. 76
Nicotinamide N-Methyltransferase as Promising Tool for Management of Gastrointestinal Neoplasms 75
Profilo dell’espressione dei geni coinvolti nel pathway dell’apoptosi nel carcinoma orale. 75
Nicotinamide n-methyltransferase: a new diagnostic marker and therapeutic target for oral carcinoma. 74
Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration and chemoresistance of Merkel cell carcinoma cells in vitro 73
Targeting nicotinamide N-methyltransferase decreased aggressiveness of osteosarcoma cells 73
Curcumin and its Analogues in Oral Squamous Cell Carcinoma: State-of-the-art and Therapeutic Potential 72
Nicotinamide N-Methyltransferase upregulation correlates with tumour differentiation in oral squamous cell carcinoma 72
Gene silencing of Nicotinamide N-methyltransferase in oral cancer cell lines: effects on tumor cell proliferation. 71
Nicotinamide N-methyltransferase: a potential target molecule for effective therapy and early diagnosis of oral squamous cell carcinoma. 71
NNMT (nicotinamide N-methyltransferase). 71
Nicotinamide N-Methyltransferase: a promising biomarker for early diagnosis and prognostic monitoring of oral squamous cell carcinoma. 70
Neurotrophins and receptors pattern expression in placentas from pregnancies complicated by HELLP Syndrome and Intrauterine Growth Restriction (IUGR). 70
Tissue and salivary Nicotinamide N-Methyltransferase: promising results for early and non-invasive diagnosis of oral squamous cell carcinoma. 70
Nicotinamide N-methyltransferase as effective diagnostic tool and promising therapeutic target for oral cancer. 70
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 69
Nicotinamide N-Methyltransferase as potential predictor of lymph node metastasis in Oral Squamous Cell Carcinoma. 68
FTIRM: an analytical approach to test the effectiveness of cisplatin treatment on PON2 silenced otscc cells 68
Enhanced expression of nicotinamide N-methyltransferase in human osteosarcoma: potential role in tumor growth and chemoresistance 67
Inflammatory cytokines and receptors in placentas from pregnancies complicated by HELLP syndrome. 67
Enzymes Dysregulation in Cancer: From Diagnosis to Therapeutical Approaches 66
Totale 9.871
Categoria #
all - tutte 54.899
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.899


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021502 0 0 0 0 0 40 104 35 96 84 110 33
2021/2022628 29 167 14 23 0 19 23 59 33 60 49 152
2022/20231.409 100 170 101 119 83 194 18 88 336 13 121 66
2023/20241.136 169 26 82 126 145 183 14 34 20 90 52 195
2024/20252.146 287 144 101 46 108 30 185 74 400 153 251 367
2025/20263.123 540 382 734 658 711 98 0 0 0 0 0 0
Totale 10.861